98 results
Page 3 of 5
8-K
EX-99.1
jno i9n2hfw749dp5ft
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
35ua0bf2i2rbor
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
CORRESP
1e3 14uekxfzroqc
13 Dec 19
Correspondence with SEC
12:00am
8-K
EX-99.2
isuod7j
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
3ip34qfe i7
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
kqwbjk7iduh hg
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
13mj6
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
mncbirwfaud6 du
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
i3lz5toaokj uujz7c
28 Jun 19
Regulation FD Disclosure
9:01am
8-K
EX-99.1
7h1la rtc31
15 Apr 19
Other Events
9:00am
8-K
EX-99.1
gjhkr1zq
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
EX-99.1
elcdakn8qmu h07x02
7 Jun 18
Other Events
7:31am